Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dicerna Pharmaceuticals Inc (DRNA) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dicerna Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1399529.
Total stock buying since 2014: $2,496,074.
Total stock sales since 2014: $221,580,149.
Total stock option exercises since 2014: $5,613,745.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 8,000 | $181,466 | 266,470 | $8,245,326 | 513,845 | $2,644,525 |
| 2020 | 10,000 | $180,600 | 1,302,649 | $30,083,686 | 334,166 | $1,440,197 |
| 2019 | 0 | $0 | 7,666,179 | $161,965,672 | 301,482 | $1,159,840 |
| 2018 | 0 | $0 | 969,611 | $13,320,209 | 48,538 | $241,884 |
| 2017 | 285,000 | $1,995,000 | 0 | $0 | 13,745,272 | $0 |
| 2016 | 38,100 | $139,008 | 23,766 | $83,656 | 34,722 | $118,749 |
| 2015 | 0 | $0 | 37,532 | $976,582 | 0 | $0 |
| 2014 | 0 | $0 | 653,907 | $6,905,018 | 2,500 | $8,550 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-12 | 0 | $0 | 0 | $0 | 220,895 | $774,636 |
| 2021-11 | 0 | $0 | 24,936 | $946,071 | 24,936 | $85,281 |
| 2021-09 | 0 | $0 | 24,640 | $520,307 | 11,581 | $0 |
| 2021-08 | 8,000 | $181,466 | 8,312 | $310,677 | 8,312 | $28,427 |
| 2021-07 | 0 | $0 | 38,312 | $1,485,023 | 41,474 | $301,127 |
| 2021-06 | 0 | $0 | 52,178 | $1,788,909 | 77,001 | $656,089 |
| 2021-05 | 0 | $0 | 4,431 | $136,071 | 4,431 | $57,292 |
| 2021-04 | 0 | $0 | 37,647 | $1,109,199 | 32,743 | $267,519 |
| 2021-03 | 0 | $0 | 12,743 | $372,040 | 12,743 | $132,848 |
| 2021-02 | 0 | $0 | 19,899 | $507,284 | 12,743 | $132,848 |
| 2021-01 | 0 | $0 | 43,372 | $1,069,745 | 66,986 | $208,458 |
| 2020-12 | 0 | $0 | 1,012,545 | $23,716,106 | 12,545 | $42,903 |
| 2020-11 | 0 | $0 | 42,545 | $945,963 | 42,545 | $430,803 |
| 2020-10 | 0 | $0 | 25,090 | $519,914 | 35,090 | $115,507 |
| 2020-09 | 10,000 | $180,600 | 0 | $0 | 21,517 | $73,588 |
| 2020-08 | 0 | $0 | 12,545 | $283,063 | 12,545 | $41,922 |
| 2020-07 | 0 | $0 | 12,545 | $333,876 | 12,545 | $40,941 |
| 2020-06 | 0 | $0 | 22,215 | $505,516 | 22,215 | $69,660 |
| 2020-05 | 0 | $0 | 25,826 | $578,701 | 25,826 | $80,385 |
| 2020-04 | 0 | $0 | 71,919 | $1,563,319 | 71,919 | $306,209 |
| 2020-03 | 0 | $0 | 12,545 | $261,740 | 12,545 | $40,941 |
| 2020-02 | 0 | $0 | 12,545 | $259,957 | 12,545 | $40,941 |
| 2020-01 | 0 | $0 | 52,329 | $1,115,531 | 52,329 | $156,397 |
| 2019-12 | 0 | $0 | 1,850,944 | $45,866,926 | 169,078 | $630,894 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-12-15 | Zeng Ling (Chief Legal Officer & Sec'y) | Option Ex | 2,562 | .00 | 0 |
| 2021-12-15 | Ciappenelli Robert D. (Chief Strategy Officer) | Option Ex | 3,425 | .00 | 0 |
| 2021-12-15 | Aradhye Shreeram (EVP & Chief Medical Officer) | Option Ex | 2,837 | .00 | 0 |
| 2021-12-15 | Pagan Douglas W. (Chief Financial Officer) | Option Ex | 2,050 | .00 | 0 |
| 2021-12-15 | Weissman James B (Chief Operating Officer & EVP) | Option Ex | 3,775 | .00 | 0 |
| 2021-12-15 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Option Ex | 3,775 | .00 | 0 |
| 2021-12-15 | Fambrough Douglas (Chief Executive Officer) | Option Ex | 13,750 | .00 | 0 |
| 2021-12-13 | Ciappenelli Robert D. (Chief Strategy Officer) | Option Ex | 8,856 | 22.58 | 199,968 |
| 2021-12-10 | Fambrough Douglas (Chief Executive Officer) | Option Ex | 179,865 | 3.19 | 574,668 |
| 2021-11-18 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Sale | 24,936 | 37.94 | 946,071 |
| 2021-11-18 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Option Ex | 24,936 | 3.42 | 85,281 |
| 2021-09-17 | Zeng Ling (Chief Legal Officer & Sec'y) | Sale | 1,334 | 21.47 | 28,640 |
| 2021-09-17 | Aradhye Shreeram (EVP & Chief Medical Officer) | Sale | 2,056 | 21.47 | 44,142 |
| 2021-09-17 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Sale | 21,250 | 21.06 | 447,525 |
| 2021-09-15 | Zeng Ling (Chief Legal Officer & Sec'y) | Option Ex | 4,556 | .00 | 0 |
| 2021-09-15 | Aradhye Shreeram (EVP & Chief Medical Officer) | Option Ex | 7,025 | .00 | 0 |
| 2021-08-10 | Fambrough Douglas (President and CEO) | Buy | 5,000 | 22.10 | 110,480 |
| 2021-08-10 | Kozin Marc D | Buy | 3,000 | 23.66 | 70,986 |
| 2021-08-02 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Sale | 8,312 | 37.38 | 310,677 |
| 2021-08-02 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Option Ex | 8,312 | 3.42 | 28,427 |
| 2021-07-06 | Paglia Regina M. (Chief Human Resources Officer) | Option Ex | 3,162 | .00 | 0 |
| 2021-07-06 | Weissman James B (Chief Operating Officer & EVP) | Sale | 30,000 | 39.09 | 1,172,700 |
| 2021-07-06 | Weissman James B (Chief Operating Officer & EVP) | Option Ex | 30,000 | 9.09 | 272,700 |
| 2021-07-01 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Sale | 8,312 | 37.58 | 312,323 |
| 2021-07-01 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Option Ex | 8,312 | 3.42 | 28,427 |
| 2021-06-25 | Paglia Regina M. (Chief Human Resources Officer) | Sale | 1,000 | 38.00 | 38,004 |
| 2021-06-25 | Paglia Regina M. (Chief Human Resources Officer) | Option Ex | 1,000 | 22.58 | 22,580 |
| 2021-06-22 | Paglia Regina M. (Chief Human Resources Officer) | Sale | 18,435 | 36.90 | 680,306 |
| 2021-06-22 | Paglia Regina M. (Chief Human Resources Officer) | Option Ex | 18,435 | 19.85 | 365,990 |
| 2021-06-15 | Pagan Douglas W. (Chief Financial Officer) | Option Ex | 6,825 | .00 | 0 |
| 2021-06-11 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Sale | 10,000 | 34.00 | 340,000 |
| 2021-06-11 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Option Ex | 10,000 | 9.09 | 90,900 |
| 2021-06-07 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Sale | 10,000 | 33.00 | 330,000 |
| 2021-06-07 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Option Ex | 10,000 | 9.09 | 90,900 |
| 2021-06-03 | Freed Martin I | Option Ex | 3,333 | .00 | 0 |
| 2021-06-03 | Gray Patrick M. | Option Ex | 3,333 | .00 | 0 |
| 2021-06-03 | Smith Cynthia | Option Ex | 3,333 | .00 | 0 |
| 2021-06-03 | Doberstein Stephen K | Option Ex | 3,333 | .00 | 0 |
| 2021-06-03 | Buchi J Kevin | Option Ex | 4,666 | .00 | 0 |
| 2021-06-01 | Paglia Regina M. (Chief Human Resources Officer) | Sale | 4,431 | 31.41 | 139,195 |
| 2021-06-01 | Paglia Regina M. (Chief Human Resources Officer) | Option Ex | 4,431 | 12.93 | 57,292 |
| 2021-06-01 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Sale | 8,312 | 31.45 | 261,404 |
| 2021-06-01 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Option Ex | 8,312 | 3.42 | 28,427 |
| 2021-05-03 | Paglia Regina M. (Chief Human Resources Officer) | Sale | 4,431 | 30.71 | 136,071 |
| 2021-05-03 | Paglia Regina M. (Chief Human Resources Officer) | Option Ex | 4,431 | 12.93 | 57,292 |
| 2021-04-30 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Sale | 10,000 | 32.00 | 320,000 |
| 2021-04-30 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Option Ex | 10,000 | 9.09 | 90,900 |
| 2021-04-29 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Sale | 10,000 | 31.00 | 310,000 |
| 2021-04-29 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Option Ex | 10,000 | 9.09 | 90,900 |
| 2021-04-16 | Weissman James B (Chief Operating Officer & EVP) | Sale | 4,904 | 29.99 | 147,070 |
| 2021-04-01 | Paglia Regina M. (Chief Human Resources Officer) | Sale | 4,431 | 25.86 | 114,563 |
| 2021-04-01 | Paglia Regina M. (Chief Human Resources Officer) | Option Ex | 4,431 | 12.93 | 57,292 |
| 2021-04-01 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Sale | 8,312 | 26.18 | 217,566 |
| 2021-04-01 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Option Ex | 8,312 | 3.42 | 28,427 |
| 2021-03-01 | Paglia Regina M. (Chief Human Resources Officer) | Sale | 4,431 | 29.20 | 129,363 |
| 2021-03-01 | Paglia Regina M. (Chief Human Resources Officer) | Option Ex | 4,431 | 12.93 | 57,292 |
| 2021-03-01 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Sale | 8,312 | 29.20 | 242,677 |
| 2021-03-01 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Option Ex | 8,312 | 9.09 | 75,556 |
| 2021-02-05 | Weissman James B (Chief Operating Officer & EVP) | Sale | 7,156 | 26.99 | 193,140 |
| 2021-02-03 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Sale | 8,312 | 25.00 | 207,800 |
| 2021-02-03 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Option Ex | 8,312 | 9.09 | 75,556 |
| 2021-02-02 | Paglia Regina M. (Chief Human Resources Officer) | Sale | 4,431 | 24.00 | 106,344 |
| 2021-02-02 | Paglia Regina M. (Chief Human Resources Officer) | Option Ex | 4,431 | 12.93 | 57,292 |
| 2021-01-25 | Paglia Regina M. (Chief Human Resources Officer) | Sale | 6,326 | 25.00 | 158,150 |
| 2021-01-25 | Paglia Regina M. (Chief Human Resources Officer) | Option Ex | 4,431 | 12.93 | 57,292 |
| 2021-01-25 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Sale | 21,630 | 25.00 | 540,750 |
| 2021-01-25 | Brown Bob D (Chief Scientific Ofr., EVP R&D) | Option Ex | 16,630 | 9.09 | 151,166 |
| 2021-01-12 | Weissman James B (Chief Operating Officer & EVP) | Sale | 5,808 | 24.08 | 139,868 |
| 2021-01-12 | Brown Bob D (See Remarks) | Sale | 5,808 | 24.07 | 139,815 |
| 2021-01-11 | Weissman James B (Chief Operating Officer & EVP) | Sale | 3,800 | 23.99 | 91,162 |
| 2021-01-08 | Paglia Regina M. (Chief Human Resources Officer) | Option Ex | 2,900 | .00 | 0 |
| 2021-01-08 | Ciappenelli Robert D. (Chief Commercial Officer) | Option Ex | 5,775 | .00 | 0 |
| 2021-01-08 | Weissman James B (Chief Operating Officer & EVP) | Option Ex | 8,650 | .00 | 0 |
| 2021-01-08 | Brown Bob D (See Remarks) | Option Ex | 8,650 | .00 | 0 |
| 2021-01-08 | Fambrough Douglas (President and CEO) | Option Ex | 19,950 | .00 | 0 |
| 2020-12-10 | Koppel Adam (Director) | Sale | 1,000,000 | 23.40 | 23,400,000 |
| 2020-12-01 | Weissman James B (Chief Operating Officer & EVP) | Sale | 4,360 | 25.21 | 109,902 |
| 2020-12-01 | Weissman James B (Chief Operating Officer & EVP) | Option Ex | 4,360 | 3.42 | 14,911 |
| 2020-12-01 | Brown Bob D (See Remarks) | Sale | 8,185 | 25.19 | 206,204 |
| 2020-12-01 | Brown Bob D (See Remarks) | Option Ex | 8,185 | 3.42 | 27,992 |
| 2020-11-04 | Paglia Regina M. (Chief Human Resources Officer) | Sale | 30,000 | 22.75 | 682,500 |
| 2020-11-04 | Paglia Regina M. (Chief Human Resources Officer) | Option Ex | 30,000 | 12.93 | 387,900 |
| 2020-11-02 | Weissman James B (Chief Operating Officer & EVP) | Sale | 4,360 | 20.95 | 91,333 |
| 2020-11-02 | Weissman James B (Chief Operating Officer & EVP) | Option Ex | 4,360 | 3.42 | 14,911 |
| 2020-11-02 | Brown Bob D (See Remarks) | Sale | 8,185 | 21.03 | 172,130 |
| 2020-11-02 | Brown Bob D (See Remarks) | Option Ex | 8,185 | 3.42 | 27,992 |
| 2020-10-20 | Weissman James B (Chief Operating Officer & EVP) | Option Ex | 10,000 | 2.97 | 29,700 |
| 2020-10-16 | Brown Bob D (See Remarks) | Sale | 16,370 | 21.00 | 343,770 |
| 2020-10-16 | Brown Bob D (See Remarks) | Option Ex | 16,370 | 3.42 | 55,985 |
| 2020-10-15 | Weissman James B (Chief Operating Officer & EVP) | Sale | 8,720 | 20.20 | 176,144 |
| 2020-10-15 | Weissman James B (Chief Operating Officer & EVP) | Option Ex | 8,720 | 3.42 | 29,822 |
| 2020-09-16 | Brown Bob D (See Remarks) | Option Ex | 21,250 | 3.42 | 72,675 |
| 2020-09-14 | Brown Bob D (See Remarks) | Option Ex | 267 | 3.42 | 913 |
| 2020-09-01 | Fambrough Douglas (President and CEO) | Buy | 10,000 | 18.06 | 180,600 |
| 2020-08-03 | Weissman James B (EVP & Chief Operating Officer) | Sale | 4,360 | 22.56 | 98,344 |
| 2020-08-03 | Weissman James B (EVP & Chief Operating Officer) | Option Ex | 4,360 | 3.19 | 13,930 |
| 2020-08-03 | Brown Bob D (See Remarks) | Sale | 8,185 | 22.57 | 184,719 |
| 2020-08-03 | Brown Bob D (See Remarks) | Option Ex | 8,185 | 3.42 | 27,992 |
| 2020-07-01 | Weissman James B (Chief Operating Officer & EVP) | Sale | 4,360 | 26.63 | 116,098 |
| 2020-07-01 | Weissman James B (Chief Operating Officer & EVP) | Option Ex | 4,360 | 2.97 | 12,949 |
| 2020-07-01 | Brown Bob D (See Remarks) | Sale | 8,185 | 26.61 | 217,778 |
| 2020-07-01 | Brown Bob D (See Remarks) | Option Ex | 8,185 | 3.42 | 27,992 |
| 2020-06-19 | Brown Bob D (See Remarks) | Sale | 9,670 | 25.00 | 241,750 |
| 2020-06-19 | Brown Bob D (See Remarks) | Option Ex | 9,670 | 2.97 | 28,719 |
| 2020-06-01 | Weissman James B (Chief Operating Officer & EVP) | Sale | 4,360 | 21.06 | 91,808 |
| 2020-06-01 | Weissman James B (Chief Operating Officer & EVP) | Option Ex | 4,360 | 2.97 | 12,949 |
| 2020-06-01 | Brown Bob D (See Remarks) | Sale | 8,185 | 21.01 | 171,958 |
| 2020-06-01 | Brown Bob D (See Remarks) | Option Ex | 8,185 | 3.42 | 27,992 |
| 2020-05-11 | Brown Bob D (See Remarks) | Sale | 13,281 | 24.00 | 318,744 |
| 2020-05-11 | Brown Bob D (See Remarks) | Option Ex | 13,281 | 2.97 | 39,444 |
| 2020-05-05 | Brown Bob D (See Remarks) | Sale | 8,185 | 21.00 | 171,885 |
| 2020-05-05 | Brown Bob D (See Remarks) | Option Ex | 8,185 | 3.42 | 27,992 |
| 2020-05-04 | Weissman James B (Chief Operating Officer & EVP) | Sale | 4,360 | 20.20 | 88,072 |
| 2020-05-04 | Weissman James B (Chief Operating Officer & EVP) | Option Ex | 4,360 | 2.97 | 12,949 |
| 2020-04-20 | Brown Bob D (See Remarks) | Sale | 13,281 | 23.00 | 305,463 |
| 2020-04-20 | Brown Bob D (See Remarks) | Option Ex | 13,281 | 2.97 | 39,444 |
| 2020-04-20 | Green John B (Chief Financial Officer) | Sale | 25,624 | 22.95 | 588,070 |
| 2020-04-20 | Green John B (Chief Financial Officer) | Option Ex | 25,624 | 5.45 | 139,650 |
| 2020-04-17 | Brown Bob D (See Remarks) | Sale | 8,185 | 21.18 | 173,358 |
| 2020-04-17 | Brown Bob D (See Remarks) | Option Ex | 8,185 | 3.42 | 27,992 |
| 2020-04-13 | Weissman James B (Chief Operating Officer & EVP) | Sale | 4,360 | 20.20 | 88,072 |
| 2020-04-13 | Weissman James B (Chief Operating Officer & EVP) | Option Ex | 4,360 | 2.97 | 12,949 |
| 2020-04-07 | Green John B (Chief Financial Officer) | Sale | 20,469 | 19.95 | 408,356 |
| 2020-04-07 | Green John B (Chief Financial Officer) | Option Ex | 20,469 | 4.21 | 86,174 |
| 2020-03-02 | Weissman James B (EVP & Chief Operating Officer) | Sale | 4,360 | 20.61 | 89,855 |
| 2020-03-02 | Weissman James B (EVP & Chief Operating Officer) | Option Ex | 4,360 | 2.97 | 12,949 |
| 2020-03-02 | Brown Bob D (See Remarks) | Sale | 8,185 | 21.00 | 171,885 |
| 2020-03-02 | Brown Bob D (See Remarks) | Option Ex | 8,185 | 3.42 | 27,992 |
| 2020-02-10 | Brown Bob D (See Remarks) | Sale | 8,185 | 21.00 | 171,885 |
| 2020-02-10 | Brown Bob D (See Remarks) | Option Ex | 8,185 | 3.42 | 27,992 |
| 2020-02-03 | Weissman James B (EVP & Chief Operating Officer) | Sale | 4,360 | 20.20 | 88,072 |
| 2020-02-03 | Weissman James B (EVP & Chief Operating Officer) | Option Ex | 4,360 | 2.97 | 12,949 |
| 2020-01-17 | Green John B (Chief Financial Officer) | Sale | 47,969 | 21.27 | 1,020,156 |
| 2020-01-17 | Green John B (Chief Financial Officer) | Option Ex | 47,969 | 2.97 | 142,467 |
| 2020-01-02 | Weissman James B (EVP & Chief Operating Officer) | Sale | 4,360 | 21.88 | 95,375 |
| 2020-01-02 | Weissman James B (EVP & Chief Operating Officer) | Option Ex | 4,360 | 3.19 | 13,930 |
| 2019-12-31 | Brown Bob D (See Remarks) | Sale | 11,941 | 22.00 | 262,702 |
| 2019-12-31 | Brown Bob D (See Remarks) | Option Ex | 16,941 | 3.19 | 54,126 |
| 2019-12-30 | Brown Bob D (See Remarks) | Sale | 22,806 | 21.93 | 500,021 |
| 2019-12-30 | Brown Bob D (See Remarks) | Option Ex | 13,136 | 3.19 | 41,969 |
| 2019-12-26 | Rosskamp Ralf (Chief Medical Officer) | Sale | 20,000 | 22.69 | 453,760 |
| 2019-12-26 | Rosskamp Ralf (Chief Medical Officer) | Option Ex | 20,000 | 2.91 | 58,200 |
| 2019-12-18 | Weissman James B (EVP & Chief Operating Officer) | Option Ex | 11,001 | 9.09 | 99,999 |
| 2019-12-18 | Fambrough Douglas (Chief Executive Officer) | Sale | 80,000 | 26.46 | 2,116,880 |
| 2019-12-18 | Fambrough Douglas (Chief Executive Officer) | Option Ex | 80,000 | 3.42 | 273,600 |
| 2019-12-17 | Fambrough Douglas (Chief Executive Officer) | Sale | 59,021 | 26.54 | 1,566,358 |
| 2019-12-11 | Green John B (Chief Financial Officer) | Option Ex | 8,000 | 5.45 | 43,600 |
| 2019-12-04 | Koppel Adam (Director) | Sale | 1,500,000 | 24.68 | 37,020,000 |
| 2019-12-02 | Weissman James B (EVP & Chief Operating Officer) | Sale | 20,000 | 26.00 | 520,000 |
| 2019-12-02 | Weissman James B (EVP & Chief Operating Officer) | Option Ex | 20,000 | 2.97 | 59,400 |
| 2019-12-02 | Kolchinsky Peter | Sale | 137,176 | 24.98 | 3,427,205 |
| 2019-11-29 | Kolchinsky Peter | Sale | 138,000 | 24.21 | 3,341,670 |
| 2019-11-27 | Kolchinsky Peter | Sale | 368,700 | 24.04 | 8,864,654 |
| 2019-11-26 | Kolchinsky Peter | Sale | 239,700 | 23.59 | 5,653,564 |
| 2019-11-25 | Kolchinsky Peter | Sale | 361,200 | 24.06 | 8,689,749 |
| 2019-11-25 | Green John B (Chief Financial Officer) | Sale | 12,500 | 24.95 | 311,875 |
| 2019-11-25 | Green John B (Chief Financial Officer) | Option Ex | 12,500 | 5.45 | 68,125 |
| 2019-11-22 | Kolchinsky Peter | Sale | 197,700 | 22.52 | 4,451,413 |
| 2019-11-21 | Kolchinsky Peter | Sale | 351,505 | 22.98 | 8,076,881 |
| 2019-11-20 | Kolchinsky Peter | Sale | 265,505 | 22.93 | 6,088,826 |
| 2019-11-19 | Weissman James B (EVP & Chief Operating Officer) | Sale | 20,000 | 24.00 | 480,000 |
| 2019-11-19 | Weissman James B (EVP & Chief Operating Officer) | Option Ex | 20,000 | 3.42 | 68,400 |
| 2019-11-19 | Koppel Adam (Director) | Sale | 1,750,000 | 22.03 | 38,552,500 |
| 2019-11-19 | Kolchinsky Peter | Sale | 397,183 | 23.92 | 9,501,411 |
| 2019-11-18 | Weissman James B (EVP & Chief Operating Officer) | Sale | 20,000 | 22.00 | 440,000 |
| 2019-11-18 | Weissman James B (EVP & Chief Operating Officer) | Option Ex | 20,000 | 3.42 | 68,400 |
| 2019-11-18 | Green John B (Chief Financial Officer) | Sale | 12,500 | 21.05 | 263,125 |
| 2019-11-18 | Green John B (Chief Financial Officer) | Option Ex | 12,500 | 5.45 | 68,125 |
| 2019-11-14 | Weissman James B (EVP & Chief Operating Officer) | Sale | 20,000 | 20.00 | 400,000 |
| 2019-11-14 | Weissman James B (EVP & Chief Operating Officer) | Option Ex | 20,000 | 3.42 | 68,400 |
| 2019-11-14 | Green John B (Chief Financial Officer) | Sale | 3,562 | 20.00 | 71,240 |
| 2019-10-31 | Weissman James B (EVP & Chief Operating Officer) | Sale | 15,000 | 18.00 | 270,000 |
| 2019-10-31 | Weissman James B (EVP & Chief Operating Officer) | Option Ex | 15,000 | 3.42 | 51,300 |
| 2019-10-31 | Green John B (Chief Financial Officer) | Sale | 12,500 | 18.00 | 225,000 |
| 2019-10-31 | Green John B (Chief Financial Officer) | Option Ex | 12,500 | 5.45 | 68,125 |
| 2019-10-18 | Weissman James B (EVP & Chief Operating Officer) | Option Ex | 4,904 | 3.42 | 16,771 |
| 2019-08-23 | Weissman James B (Chief Business Officer) | Sale | 14,680 | 13.07 | 191,838 |
| 2019-05-29 | Koppel Adam (Director) | Sale | 1,600,000 | 12.50 | 20,000,000 |
| 2019-04-02 | Weissman James B (Chief Business Officer) | Sale | 15,000 | 15.00 | 225,000 |
| 2019-04-02 | Weissman James B (Chief Business Officer) | Option Ex | 15,000 | 3.42 | 51,300 |
| 2018-11-06 | Halak Brian K (Director) | Sale | 104,328 | 13.67 | 1,426,163 |
| 2018-11-05 | Halak Brian K (Director) | Sale | 39,901 | 12.98 | 517,914 |
| 2018-11-02 | Halak Brian K (Director) | Sale | 190,771 | 13.47 | 2,569,685 |
| 2018-11-01 | Halak Brian K (Director) | Sale | 189,575 | 13.37 | 2,534,617 |
| 2018-10-31 | Halak Brian K (Director) | Sale | 129,629 | 13.60 | 1,762,954 |
| 2018-10-30 | Halak Brian K (Director) | Sale | 245,096 | 13.99 | 3,430,118 |
| 2018-09-05 | Weissman James B (Chief Business Officer) | Sale | 2,301 | 17.50 | 40,267 |
| 2018-09-05 | Weissman James B (Chief Business Officer) | Option Ex | 2,301 | 3.42 | 7,869 |
| 2018-08-17 | Weissman James B (Chief Business Officer) | Option Ex | 14,680 | 3.42 | 50,205 |
| 2018-08-15 | Langer Dennis | Sale | 38,341 | 16.00 | 613,456 |
| 2018-06-07 | Halak Brian K (Director) | Option Ex | 21,197 | 7.00 | 148,379 |
| 2018-05-09 | Weissman James B (Chief Business Officer) | Sale | 10,000 | 15.00 | 150,000 |
| 2018-05-09 | Weissman James B (Chief Business Officer) | Option Ex | 10,000 | 3.42 | 34,200 |
| 2018-05-09 | Brown Bob D (Chief Scientific Officer) | Sale | 9,669 | 15.00 | 145,035 |
| 2018-04-20 | Weissman James B (Chief Business Officer) | Sale | 8,965 | 13.00 | 116,545 |
| 2018-03-19 | Weissman James B (Chief Business Officer) | Sale | 1,035 | 13.00 | 13,455 |
| 2018-01-26 | Langer Dennis (Director) | Option Ex | 360 | 3.42 | 1,231 |
| 2017-12-18 | Koppel Adam (Director) | Buy | 285,000 | 7.00 | 1,995,000 |
| 2017-12-18 | Koppel Adam (Director) | Option Ex | 8,454,388 | .00 | 0 |
| 2017-12-18 | Kolchinsky Peter | Option Ex | 2,645,442 | .00 | 0 |
| 2017-12-18 | Ra Capital Healthcare Fund Lp | Option Ex | 2,645,442 | .00 | 0 |
| 2016-11-16 | Langer Dennis (Director) | Sale | 23,766 | 3.52 | 83,656 |
| 2016-11-15 | Fambrough Douglas (Chief Executive Officer) | Buy | 16,500 | 3.63 | 59,895 |
| 2016-11-14 | Fambrough Douglas (Chief Executive Officer) | Buy | 16,600 | 3.78 | 62,748 |
| 2016-05-12 | Weissman James B (Chief Business Officer) | Buy | 5,000 | 3.27 | 16,365 |
| 2016-02-03 | Langer Dennis (Director) | Option Ex | 34,722 | 3.42 | 118,749 |
| 2015-02-20 | Kaneko Yasunori (Other) | Sale | 37,532 | 26.02 | 976,582 |
| 2014-12-17 | Fambrough Douglas (Chief Executive Officer) | Option Ex | 2,500 | 3.42 | 8,550 |
| 2014-11-25 | Deerfield Private Design International Ii, L.p. | Sale | 121,965 | 11.50 | 1,402,597 |
| 2014-11-24 | Deerfield Private Design International Ii, L.p. | Sale | 100,000 | 11.54 | 1,154,500 |
| 2014-11-21 | Deerfield Private Design International Ii, L.p. | Sale | 100,000 | 11.00 | 1,100,000 |
| 2014-11-07 | Deerfield Private Design International Ii, L.p. | Sale | 214,164 | 9.20 | 1,970,308 |
| 2014-10-15 | Deerfield Private Design International Ii, L.p. | Sale | 51,449 | 10.01 | 515,004 |
| 2014-10-14 | Deerfield Private Design International Ii, L.p. | Sale | 36,115 | 11.02 | 397,987 |
| 2014-10-10 | Deerfield Private Design International Ii, L.p. | Sale | 30,214 | 12.07 | 364,622 |
Insider trading activities including stock purchases, stock sales, and option exercises of DRNA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dicerna Pharmaceuticals Inc (symbol DRNA, CIK number 1399529) see the Securities and Exchange Commission (SEC) website.